Peter DeMuth

Insider Reports History

Location
Boston, MA
Signature
/s/ Peter DeMuth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter DeMuth:

Company Role Class Num Shares Value Price $ Report Date Ownership
Elicio Therapeutics, Inc. Chief Scientific Officer Common Stock 21,543 $171,482 $7.96 02 Feb 2026 Direct
Elicio Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 41,600 02 Feb 2026 Direct

Insider Reports Filed by Peter DeMuth

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELTX Elicio Therapeutics, Inc. 02 Feb 2026 2 $0 4 Chief Scientific Officer 03 Feb 2026, 16:38
ELTX Elicio Therapeutics, Inc. 09 Dec 2025 2 +$1,596 4 Chief Scientific Officer 10 Dec 2025, 17:05
ELTX Elicio Therapeutics, Inc. 03 Feb 2025 1 $0 4 Chief Scientific Officer 04 Feb 2025, 16:11
ELTX Elicio Therapeutics, Inc. 16 Dec 2024 2 +$1,680 4 Chief Scientific Officer 18 Dec 2024, 16:51
ELTX Elicio Therapeutics, Inc. 30 Sep 2024 1 $0 4 Chief Scientific Officer 02 Oct 2024, 16:13
ELTX Elicio Therapeutics, Inc. 01 Feb 2024 2 $0 4 Chief Scientific Officer 05 Feb 2024, 06:01
ELTX Elicio Therapeutics, Inc. 01 Jun 2023 0 $0 3 Chief Scientific Officer 07 Jun 2023, 21:53